• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Apollo Endosurgery

DTW #45: Kamen talks 3D organs; Todd Pope returns as CEO; Joe Mulling says medtech’s time is now

February 12, 2021 By Tom Salemi

Please lift this jam-packed episode with your legs, not your back. We’ll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. WellAir’s Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID Joe Mullings of the Mullings Group explains why now is […]

Filed Under: Business/Financial News, Device Talks Podcasts, Featured, Special Content Tagged With: Apollo Endosurgery, Canary Medical, DeviceTalks Weekly, iRhythm Technologies Inc., Medtronic, Philips

J&J, Boston Sci vet McKhann to become Apollo Endosurgery’s CEO

February 8, 2021 By Sean Whooley

Apollo Endosurgery (NSDQ:APEN) announced today that Charles (Chas) McKhann will become its new CEO and join its board of directors. Current CEO Todd Newton will help facilitate the transition process and agreed to serve as a consultant to the company for up to six months following McKhann’s hire, which becomes effective on March 1, according to […]

Filed Under: Business/Financial News, Endoscopic, Featured, Surgical Tagged With: Apollo Endosurgery, Personnel Moves

Apollo Endosurgery lands $20m in debt placement

August 13, 2019 By Brad Perriello

Apollo Endosurgery (NSDQ:APEN) said yesterday that it closed a private debt placement worth $20 million. The debt pays 6.0% annually and can be converted to APEN shares at $3.25 apiece, with Austin, Texas-based Apollo able to force the conversion of the unsecured debentures. Apollo said it plans to use the proceeds for working capital and general […]

Filed Under: Funding Roundup, Wall Street Beat, Weight loss Tagged With: Apollo Endosurgery

Apollo Endosurgery beats on Q2 sales, misses on earnings

July 24, 2019 By Nancy Crotti

Apollo Endosurgery (NSDQ:APEN) reported second-quarter results yesterday that beat analysts’ expectations for sales but missed on earnings. The Austin, Texas-based company reported a net loss of -$8.8 million, or -40¢ per share, on sales of $14.3 million for the three months ended June 30. Analysts on Wall Street were looking for losses per share of […]

Filed Under: Blog, Business/Financial News, Endoscopic, News Well, Wall Street Beat Tagged With: Apollo Endosurgery, ReShape Lifesciences

Intersect ENT lures Hologic’s West for CEO | Personnel Moves, June 28, 2019

June 28, 2019 By Brad Perriello

Intersect ENT (NSDQ:XENT) yesterday named Hologic (NSDQ:HOLX) executive Tom West to be its new president & CEO effective July 22. West, who has been president of Hologic’s diagnostics solutions division since October 2014, is a Johnson & Johnson (NYSE:JNJ) veteran, Menlo Park, Calif.-based Intersect ENT said. The company in May tapped lead director Kieran Gallahue to […]

Filed Under: Business/Financial News, Featured Tagged With: Apollo Endosurgery, Globus Medical, intersectent, Personnel Moves, Pfizer

Apollo Endosurgery updates labeling on intragastric balloon

June 14, 2019 By Nancy Crotti

Apollo Endosurgery (NSDQ:APEN) said today that the FDA has approved its proposed labeling updates for the Orbera intragastric liquid-filled balloon system, which is used to treat obesity. The goal of the labeling updates is to improve patient safety and they will take effect immediately, according to the Austin, Texas-based company. The Orbera system and Reshape […]

Filed Under: Endoscopic, Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance, Weight loss Tagged With: Apollo Endosurgery, FDA, ReShape Lifesciences

Apollo Endosurgery touts results of stomach-stapling study

February 20, 2019 By Nancy Crotti

  Apollo Endosurgery (NSDQ:APEN) has reported key data from 1,000 patients who underwent endoscopic gastroplasty using the company’s OverStitch device. Published in the journal Gastrointestinal Endoscopy, the data include a mean total weight loss of 14.8%±8.5% at 18 months. Three months following surgery, the impact on obesity-related comorbidities included the complete remission of: 13 of 17 cases […]

Filed Under: Clinical Trials, Endoscopic, News Well, Surgical, Weight loss Tagged With: Apollo Endosurgery

Analyst downgrades pressure medtech stocks

January 3, 2019 By Brad Perriello

Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]

Filed Under: Featured, Wall Street Beat Tagged With: Abbott, Apollo Endosurgery, Bausch + Lomb, Baxter, Bayer, Globus Medical, Henry Schein Inc., Hologic, Insulet, Medtronic, Smith & Nephew, Stryker, Tactile Systems Technology, Zimmer Biomet

Apollo Endosurgery deals Lap-Band to ReShape Lifesciences for up to $17m

December 18, 2018 By Brad Perriello

Apollo Endosurgery (NSDQ:APEN) said today that it dealt its Lap-Band gastric banding device to ReShape Lifesciences (NSDQ:RSLS) in return for up to $17 million and ReShape’s intra-gastric balloon, which Apollo plans to eventually discontinue. Austin, Texas-based Apollo said the exchange closed yesterday with $10 million in cash and the balloon from ReShape. Further payments of $2 […]

Filed Under: Featured, Mergers & Acquisitions, Wall Street Beat, Weight loss Tagged With: Apollo Endosurgery, ReShape Lifesciences

Apollo Endosurgery wins expanded FDA nod for OverStitch Sx system

June 29, 2018 By Fink Densford

Apollo Endosurgery said today it won special FDA 510(k) clearance for its OverStitch Sx endoscopic suturing system, an accessory for its already cleared OverStitch Sx system intended to simplify attachment of the device to compatible endoscopes. The Austin, Texas-based company said that the special clearance is the last regulatory nod it needed before it could introduce […]

Filed Under: 510(k), Endoscopic, Food & Drug Administration (FDA), Regulatory/Compliance, Surgical Tagged With: Apollo Endosurgery

Apollo Endosurgery closes $24m round

June 25, 2018 By Fink Densford

Apollo Endosurgery said today it closed a $23.7 million round of financing. In the offering, the Austin, Texas-based company offered approximately 4.3 million shares of common stock at $5.50 per share, including 562,055 shares sold under an underwriter’s option to purchase additional shares. All shares offered in the round were sold by Apollo, the company said, […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Apollo Endosurgery

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS